---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-050631"
form_type: "8-K"
ticker: "CDT"
cik: "0001896212"
company_name: "CDT Equity Inc."
filed_at: "2026-11-09T13:00:18+00:00"
generated_at: "2026-11-09T13:05:59.188655+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.78
calibrated_materiality_score: 0.78
confidence: "high"
source: SEC EDGAR
---

# Ex-CEO Regan's Corvus proposes to buy CDT Equity at $2.00/share, a 96.3% premium

## Summary
- Dr. Andrew Regan, CDT's former CEO, delivered a Nov. 5, 2026 letter stating Corvus Capital intends to propose acquiring all outstanding CDT common stock at $2.00/share.
- The $2.00 price is a 96.3% premium, on a post-split basis, to CDT's Nov. 4, 2026 closing price; the proposal is non-binding and no definitive terms have been received.
- Board plans a special committee of independent directors with full authority to consider, negotiate and vote on the proposal and any other strategic alternatives.
- Regan acts as a significant stockholder through his own shares plus beneficial ownership of Corvus Capital Limited and Manoira Limited.
- Company cautions there is no assurance a transaction will result or on its timing, terms and conditions.

## SEC filing metadata
- accession: 0001493152-26-050631
- form_type: 8-K
- ticker: CDT
- cik: 0001896212
- company_name: CDT Equity Inc.
- filed_at: 2026-11-09T13:00:18+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.78
- calibrated_materiality_score: 0.78
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1896212/000149315226050631/0001493152-26-050631-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1896212/000149315226050631/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-050631
- JSON: https://secwatch.observer/filing/0001493152-26-050631.json
- Plain text: https://secwatch.observer/filing/0001493152-26-050631.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.